Revised guidelines on preoperative autologous blood donation
Require detailed assessment ofpatients and documentation Autologous transfusion comprises several quite different procedures, including preoperative autologous donation, intraoperative and postoperative blood salvage, and acute normovolaemic haemodilution (usually done immediately before surgery). Guidelines published this month in Transfusion Medicine focus on preoperative autologous donation,' which allows the storage of blood in the liquid state for up to 42 days before transfusion back to the donor.
Preoperative autologous donation presupposes that blood is being used for elective surgery in which appreciable blood loss is expected in a patient who is fit enough to donate several units of blood. These factors will limit the procedure to at best 10% of all the blood used during surgery. In the United States about 6% of blood used is autologous donation2; in Britain the proportion is much less and certainly under 1%. In a recent pilot study in Newcastle autologous blood donated preoperatively accounted for only 0-4% of the total blood used in the region.3 About three quarters of the units were used, and this compares favourably with an American survey, which found that 60% of the autologous blood donated preoperatively was returned to the patient.2 The survey did not report on how much of the blood was transfused just because it was available; having autologous blood available should not be the sole reason for transfusing it -as the guidelines indicate.
The American survey found that about one in 40 of all preoperatively donated units (or about 6% of unused units) were transfused into other patients. The British guidelines rightly prohibit this practice: not only is it unnecessary, but it could also be potentially dangerous to recipients of this blood. Donors of preoperatively donated blood will, on average, be less healthy than routine blood donors, and using their blood would be contrary to the philosophy of the British blood transfusion service, which is to use blood from healthy donors.
The guidelines emphasise the importance of assessment of the donor by both the referring doctor and the doctor who will be responsible for collecting and storing the blood. Such assessments and their documentation are time consuming. A printed request form, which will inevitably be completed by the most junior member of the surgical team, is not enough. A request for preoperative autologous donation should be regarded in the same way as any other request for consultant intervention in the care of a patient. The fact that blood has been deposited preoperatively; the results of clinical assessment; the results of tests for hepatitis B surface antigen, antibody to hepatitis C, antibody to HIV-1 and HIV-2, and syphilis; and completed consent forms should be entered in the patient's notes. By itself age is not a bar on donation; elderly people can safely donate blood, provided that iron stores are not depleted (a special concern in elderly women4).
Autologous transfusion became fashionable in the early 1980s, when it was perceived as being a safe way to avoid transmission of viral disease, particularly HIV. With the introduction of mandatory testing for HIV-1 and HIV-2 and hepatitis C virus since then, what advantages, if any, remain? Certainly autologous blood will prevent alloimmunisation and there are suggestions that postoperative infection, particularly after orthopaedic procedures, may be less.5 But clearly most of the hazards of blood transfusion are related to errors in documentation and recording6; in this respect the guidelines provide clear, practical advice. They also provide a helpful information sheet for patients.
Will autologous transfusion in Britain become as commonplace as it is in the United States? While neither encouraging nor discouraging this possibility the guidelines provide a framework that should ensure the quality and safety of the process. This will cost money-the resources it attracts will determine how popular the procedure becomes.
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